Valuation: genOway

Market Cap 22.5M 25.96M 21.23M 19.26M 36.13M 2.49B 36.39M 254M 97.71M 1.26B 97.52M 95.37M 4.01B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.22M 33.72M 27.57M 25.01M 46.92M 3.23B 47.26M 329M 127M 1.64B 127M 124M 5.21B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-2.46%
1 week-3.64%
Current month-4.03%
1 month-2.86%
3 months-2.46%
6 months-2.46%
Current year-12.18%
1 week 2.38
Extreme 2.38
2.5
1 month 2.38
Extreme 2.38
2.53
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/1/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%-3.64%-14.39%-34.97% 25.96M
+0.28%-3.81%-2.27%+7.52% 45.63B
-1.56%-2.94%+335.56%+533.60% 43.96B
+1.65%+3.82%+44.70%+27.11% 43.73B
-1.91%-0.77%+4.97%+74.11% 40.23B
+0.34%-4.03%+9.34%+38.90% 31.86B
-11.90%-13.21% - - 17.4B
+0.74%+1.51%+20.84%+114.24% 16.62B
+1.55%+2.87%+16.11%+32.30% 14.46B
+0.18%-2.25%+80.27%+32.02% 13.04B
Average -1.28%-2.78%+55.01%+91.65% 26.69B
Weighted average by Cap. -0.77%-2.66%+75.04%+128.19%

Financials

2024 2025
Net sales 27.53M 31.77M 25.98M 23.57M 44.22M 3.05B 44.54M 310M 120M 1.54B 119M 117M 4.91B 28.6M 33.01M 26.99M 24.49M 45.93M 3.16B 46.27M 322M 124M 1.6B 124M 121M 5.1B
Net income 1.83M 2.11M 1.73M 1.57M 2.94M 203M 2.96M 20.63M 7.95M 103M 7.94M 7.76M 327M 928K 1.07M 876K 794K 1.49M 103M 1.5M 10.46M 4.03M 52.06M 4.02M 3.93M 166M
Net Debt 623K 719K 588K 533K 1M 68.91M 1.01M 7.02M 2.71M 34.96M 2.7M 2.64M 111M 6.72M 7.75M 6.34M 5.75M 10.79M 743M 10.87M 75.72M 29.18M 377M 29.12M 28.48M 1.2B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
15/09/26 2.380 -2.46% 4,387
14/09/26 €2.440 -1.21% 1,408
11/09/26 €2.470 -1.20% 1,007
10/09/26 €2.500 0.00% 821
09/09/26 €2.500 +1.21% 212
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!